FDA Purposely Delaying Adult Stem Cell Therapy to Protect Big Pharma

Physicians have in their hands a remarkable way of using adult stem cells to deal with the frailty and disabilities of young and old. The stem cells are autologous derived from the patients own bone marrow or umbilical cord, separating the stem cells from blood cells, and infused back into the patient according to precise CBER guidelines and without any ethical issues associated to it like embryonic stem cells. It would be such a leap from today’s medical diagnostics and treatments; it could only be called revolutionary. However, the FDA has deemed the medical procedure as a “drug,” which are cells from a patients own body. Following their own protocols from the FDA’s past, no medical procedure has ever been categorized as a “drug” and mandated to the same arduous phases of clinical trials, especially coming from the patients own body. Hundreds procedures come to mind like blood transfusions, fertility clinics, allogeneic transfusions (donor or non-autologous), organ transplant, etc… They all follow State Medical Board and FDA guidelines on procedures, however never subjected to clinical trials like a drug. The question is why? Bone marrow transplants have been performed safely for decades. In fact, Dr. Cox from the University of Texas has already proven that bone marrow stem cell therapies are safe under the FDA’s clinical trial protocols of drug testing. Delaying adult stem cell therapies for 15 to 20 years will cost in terms of morbidity and mortality billions of dollars in medical expenses.
Meanwhile, politicians continue to get sidetracked with the same old controversies of embryonic stem cells. Research has discovered that embryonic and fetal stem cells are not manageable and proliferate to tumors. Adult stem cells like umbilical and bone marrow are completely safe and have all the safeguards and potential to regenerate tissues. However, adult stem cell therapies stalled with funding and regulations are treated unfairly under the same stigma of embryonic stem cells. Now with the discovery of IPS cells, which can take adult stem cells from patients and turned back to stem cells that can later differiate to other tissues in the body, the embryonic stem cell controversy should be dead in the water. Politicians being intentionally sidetracked, along with FDA treating autologous stem cells as “drug,” one must wonder if the influential powers of big pharma are purposely delaying the approval of these treatments. The FDA currently has former pharmaceutical executives on their board making unprecedented decisions on autologous stem cell therapies. Many would consider this a conflict of interest considering stem cell therapies would potentially reduce the sales of drugs substantially. Approving autologous stem cell therapies would compromise billions of dollars for big pharma, so one would assume, approving any procedure would comprise their interests. I strongly believe that the public should be aware of this outrage. Currently FDA is seeking an injunction against Regenerative Sciences from Colorado, and they are suing the FDA. The outcome of this case can change how medicine is practiced forever. http://repairstemcell.wordpress.com/...lt-stem-cells/

I forwarded this message to 60 Minutes, Dateline, MSNBC, 20/20, NY Times, and Washington Post. I am trying to get the message out. I also have sent a message to U.S. Senators and some Congressmen including the President. We need the public to become aware of the outrage.